Mode VC
Emily Minkow

Emily Minkow

Managing Director, Venture atRA Capital ManagementMassachusetts
Full bioFirm profile

Emily Minkow is a Managing Director at RA Capital Management focusing on venture-stage investments. She has held leadership roles at Prevail Therapeutics, Stylus Medicine, and Aliada Therapeutics.

What Emily can write

Writes checks of$3M to $30M+
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

RA Capital Management writes $3M to $30M+ checks, larger than 93% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: RA Capital Management.

Career

  1. Frankel Group · strategy consulting
  2. Celgene Corporation · positions of increasing responsibility in business development, global marketing, Principal to the Chairman and CEO
  3. Prevail Therapeutics · Chief Business Officer
  4. Raven · Venture Partner
  5. RA Capital Management · Managing Director, Venture
    Now
  6. Celgene Corporation · Principal to the Chairman and CEO
  7. Stylus Medicine · Interim CEO
  8. Aliada Therapeutics · Consulting Chief Business Officer

Investments named in public bios

Stylus MedicineAliada Therapeutics

Focus

biotechventure-stage investmentsgenome engineeringgene therapyalzheimer's treatmentHealthcare

Education

Princeton University, BAHarvard Business School, MBA

Also at RA Capital Management

Adam Kaye
Adam KayeSenior Managing Director and Partner, Structured Capital
Kyle Teamey
Kyle TeameyManaging Partner, Planetary Health
Laura Tadvalkar
Laura TadvalkarManaging Director, Venture
Nandita Shangari
Nandita ShangariManaging Director, Venture
Peter Kolchinsky
Peter KolchinskyManaging Partner
Rajeev Shah
Rajeev ShahManaging Partner
Tess Cameron
Tess CameronManaging Director, Venture
Brigid O'BrienManaging Partner, Planetary Health

Partners like Emily

At firms with a similar stage, sector and check size.

Ali Tamaseb
Ali TamasebGeneral Partner, DCVC
Colin Greenspon
Colin GreensponCo-Founder, Narya Capital
Po BronsonGeneral Partner & Managing Director, SOSV SF, SOSV SF & NY (Fka IndieBio)
David FriedbergCEO and Partner, The Production Board (TPB)
Pete Bastien
Pete BastienPresident & Partner, Hitachi Ventures
Andrew Beebe
Andrew BeebeManaging Director, Obvious Ventures

Alert me when RA Capital Management is active

One email when Emily's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Emily Minkow?

Emily Minkow is a Managing Director at RA Capital Management focusing on venture-stage investments. She has held leadership roles at Prevail Therapeutics, Stylus Medicine, and Aliada Therapeutics.

How much does Emily Minkow invest?

Emily Minkow invests through RA Capital Management, which writes checks of $3M to $30M+ at pre-seed, seed, series a, series b.

How do I pitch Emily Minkow?

A warm intro from a founder RA Capital Management backed works best.

What did Emily Minkow do before RA Capital Management?

strategy consulting at Frankel Group; positions of increasing responsibility in business development, global marketing, Principal to the Chairman and CEO at Celgene Corporation; Chief Business Officer at Prevail Therapeutics; Venture Partner at Raven; Principal to the Chairman and CEO at Celgene Corporation; Interim CEO at Stylus Medicine; Consulting Chief Business Officer at Aliada Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.